Chemed (NYSE:CHE – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it compare to its competitors? We will compare Chemed to similar companies based on the strength of its valuation, risk, earnings, analyst recommendations, profitability, dividends and institutional ownership.
Risk & Volatility
Chemed has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Chemed’s competitors have a beta of 0.98, suggesting that their average stock price is 2% less volatile than the S&P 500.
Insider and Institutional Ownership
95.8% of Chemed shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares Chemed and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Chemed | 10.61% | 35.18% | 19.43% |
| Chemed Competitors | -8.02% | -140.32% | -1.38% |
Earnings & Valuation
This table compares Chemed and its competitors revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Chemed | $2.53 billion | $265.24 million | 25.87 |
| Chemed Competitors | $21.12 billion | $288.54 million | 7.05 |
Chemed’s competitors have higher revenue and earnings than Chemed. Chemed is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Dividends
Chemed pays an annual dividend of $2.80 per share and has a dividend yield of 0.5%. Chemed pays out 13.4% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 24.7% of their earnings in the form of a dividend. Chemed has raised its dividend for 16 consecutive years.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Chemed and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Chemed | 0 | 4 | 3 | 0 | 2.43 |
| Chemed Competitors | 1861 | 7730 | 13356 | 821 | 2.55 |
Chemed presently has a consensus price target of $603.00, suggesting a potential upside of 11.51%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.95%. Given Chemed’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Chemed has less favorable growth aspects than its competitors.
Summary
Chemed competitors beat Chemed on 9 of the 15 factors compared.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
